コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 reated wash showed a substantial increase in lactic, acetic and succinic acids Sensory analysis deter
2 all fermentations increased the contents of lactic, acetic, and hexanoic acids, while reducing the c
3 tween REF and Bio21B breads, while the acids lactic, acetic, phenyllactic, 4-OH-phenyllactic and indo
6 id (AG-G), 3-indolyl-(2R)-O-beta-d-glycoside lactic acid (ILA-G) and epi-DPA-3'-O-beta-glucopyranosid
10 by nanoprecipitation, using poly (d)(,)(l)(-)lactic acid (PLA)/poly (d)(,)(l)(-)lactic-co-glycolic ac
11 o encapsulate ATRA in largely uniform poly L-lactic acid (PLLA) microparticles, with the efficiency o
15 significantly greater pressor response than lactic acid alone, while administration of APETx2 inhibi
18 ic changes included decline in pH, increased lactic acid and arterial partial pressure of carbon diox
19 trus extract, maltodextrin, sodium chloride, lactic acid and citric acid (AuraShield L) to inhibit th
22 li from women with non-optimal produced less lactic acid and induced greater inflammatory cytokine pr
23 ic muscle ischaemia leads to accumulation of lactic acid and other inflammatory mediators with a subs
25 The acid modification was performed with 3% lactic acid and the oxidation was performed with 1.5% ac
28 re, commercial soy drink was fermented by 11 lactic acid bacteria (LAB) and 9 bifidobacteria strains.
29 liquid-state fermentation (LSF) by selected lactic acid bacteria (LAB) and Rhizopus oligosporus fung
31 perties of leavened baked goods also because Lactic acid bacteria (LAB) and yeasts produce bioactive
36 al-based foods, sourdough fermentation using Lactic Acid Bacteria (LAB) has been recently rediscovere
38 t of fermentation assisted by four different lactic acid bacteria (LAB) on polyphenols, carotenoids,
40 This research investigated the influence of lactic acid bacteria (LAB) strains on ester levels in Bo
44 ility spectrometry (GC-IMS) to differentiate lactic acid bacteria (LAB) through target identification
46 aerobic fungus next to facultative anaerobic lactic acid bacteria and the product-forming anaerobes.
50 in oesophageal adenocarcinoma (p=0.028), and lactic acid bacteria dominated the microenvironment in s
52 Bioactive peptides have been identified in lactic acid bacteria fermented foods including cultured
53 ties, delaying total aerobic mesophilic, and lactic acid bacteria growth, especially in samples with
55 c and hydroxybenzoic acids were subjected to lactic acid bacteria metabolism: caffeic and protocatech
56 impact of fermentation with five starters of lactic acid bacteria on the sensory quality and flavor-a
57 own about gut-pathogen secretomes, impact of lactic acid bacteria secretomes on host-pathogen interac
58 ted the capability of selected autochthonous lactic acid bacteria to enrich the portfolio of bioactiv
59 he aim of this work is to explore the use of lactic acid bacteria to reduce the amount of mercury sol
62 or degrading AFM(1) in milk including yeast, lactic acid bacteria, enzyme, peroxide, ozone, UV light
63 c-anoxic interfaces, H(2) O(2) production by lactic acid bacteria, the oxidative burst of phagocytes
67 oncentration of monocarboxylic acid ligand l-lactic acid by varying the ratio of Zn(2+) to ligand fro
69 dy, we show that MVs isolated from the human lactic acid commensal bacteria Pediococcus pentosaceus s
70 t were monitored included alcoholic proof, l-lactic acid content, glucose+fructose and acetic acid co
72 ich amounted to 1.1 g/100 g dw., whereas the lactic acid fermentation allowed the increase to as much
76 ree combinations of bioprocessing methods by lactic acid fermentation, cell wall hydrolyzing enzymes
77 cterized by increased glycolysis followed by lactic acid fermentation, even in the presence of abunda
78 sage-number NF54 parasites exposed to 8.2 mM lactic acid for various times were monitored using blood
82 92 and DSM 20174 converted all malic acid to lactic acid in sea buckthorn and chokeberry juices, resp
84 ications, real-time 3D OCT imaging of pH and lactic acid in the anterior chamber of a fish eye was re
88 ficient C. muridarum was more susceptible to lactic acid killing, and the pGP3 deficiency also signif
93 al adhesion on the tooth surface; subsequent lactic acid production reduces the local pH, resulting i
95 ures and rapid test indices (i.e., water and lactic acid retention capacities, oil binding capacity a
97 e malic acid, succinic acid, citric acid and lactic acid solutions, any coloration was mainly due to
98 daily continuous medium exchange and 8.2 mM lactic acid supplementation increased gametocytemia appr
99 t gametocytes continuously exposed to 8.2 mM lactic acid supplementations were more infectious to Ano
100 ota were more inflammatory and produced less lactic acid than isolates from women with optimal microb
101 transporter MCT1 is a passive transporter of lactic acid that has attracted interest as a target for
104 at pharmacologic inhibitors of MCT1-mediated lactic acid transport may not effectively prevent metast
105 anifold knockout strain lacking all putative lactic acid transporters, we conclude that the yeast pla
108 cid and 3-4-dihydroxyhydrocinnamic acid) and lactic acid were identified after 72 h fermentation.
115 ioplastic films were developed based on poly(lactic acid) (PLA) and poly(butylene adipate-co-terephth
116 cator was developed using nanofibers of poly(lactic acid) (PLA) and polyethylene oxide (PEO) combined
118 poly(ethylene terephthalate) (PET) and poly(lactic acid) (PLA) to clean H(2) fuel and a variety of o
119 Poly(butylene succinate) (PBS) and poly(lactic acid) (PLA) were melt-blended and formed into a f
120 olymers, in comparison to non-iodinated poly(lactic acid) (PLA), validated their functionality as rad
121 esized a prodrug for PTX (7-OH), using oligo(lactic acid) as a novel pro-moiety (o(LA)(8)-PTX) specif
123 ticancer drugs for injection, acyl and oligo(lactic acid) ester prodrugs have been synthesized for PE
127 three-dimensional (3D)-printed graphene/poly(lactic acid) filament electrode that is pretreated to in
129 e, we investigated the cellular fate of poly(lactic acid) nanoparticles presenting different surface
133 hoxy poly(ethylene glycol)(2000)-block-poly (lactic acid)(1800) (mPEG(2000)-b-PLA(1800)) and (mPEG(40
135 is work, we evaluated the potential for poly(lactic acid)/carboxyl-multiwalled carbon nanotube (PLA/
136 heres-loaded with AL (CH/nHA-AL) into poly(L-lactic acid)/nanohydroxyapatite (PLLA/nHA) matrix to pre
137 ed poly(ethylene glycol)-poly(l-lysine)-poly(lactic acid)] and evaluated this system with regard to s
138 utant female mosquitoes are not attracted to lactic acid, a behaviorally active component of human sw
141 Significant variations in lipid, amino acid, lactic acid, and nucleic acid content were found between
142 dc = 1,4-benzenedicarboxylic acid, l-lac = l-lactic acid, dmf = N,N'-dimethylformamide) and observed
144 cid, d-sphingosine, kynurenic acid, indole-3-lactic acid, indole-3-acetic acid, and betaine were obse
145 um l-lactate, an organic salt derived from l-lactic acid, is used in many fields such as food, pharma
146 lystyrene, poly(methyl methacrylate), poly-L-lactic acid, polycaprolactone were tested and validated.
147 abolizes both glucose and sucrose, producing lactic acid, reducing the local pH, and causing dental c
148 was likely dependent on L. murinus-produced lactic acid, since pH neutralization of the conditioned
149 hydroxymethylfurfural) and carboxylic acids (lactic acid, succinic acid, fumaric acid, malic acid, it
150 ease in sucrose and increases in ethanol and lactic acid, suggesting that resource competition shapes
151 uninfected mosquitoes to compounds including lactic acid, tetradecanoic acid and benzothiazole, sugge
154 o purple to pink color change in response to lactic acid, which is an indicator of microbial spoilage
157 ultrahigh molecular weight amorphous poly-l-lactic acid-based BRS (APTITUDE, Amaranth Medical [AMA])
158 microfiber patterns are obtained from poly(l-lactic acid-co-caprolactone) (PLCL) using NFEP and compl
160 ted nanoprecipitation, we have prepared poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles with
163 Wafers were loaded with 50% w/w TMZ in poly(lactic acid-glycolic acid) (PLGA) and showed reliable re
165 rphins in modulating ASIC function to effect lactic acid-mediated reflex increase in arterial pressur
166 orphins by which the opioids can enhance the lactic acid-mediated reflex increase in arterial pressur
167 8)-PTX-PM at 10 and 50% w/w loading, PTX and lactic acid-PTX are major bioactive metabolites, respect
168 - and 3-fold higher plasma AUC(0-24) of PTX, lactic acid-PTX, and o(LA)(2)-PTX (o(LA)(0-2)-PTX), resp
178 loped an off-the-shelf alternative, a poly(l-lactic) acid (PLLA) bioengineered ACL matrix, and demons
179 these community state types are dominated by lactic-acid producing Lactobacillus spp. while the fifth
180 lated to anode respiration (Geobacteraceae), lactic-acid production (Lactobacillales), and syntrophic
181 inotrope score at least 75 mug/kg per min or lactic acidaemia at least 4 mmol/L) at time of inclusion
183 , it is known to induce metformin-associated lactic acidosis (MALA), a severe medical condition with
184 nificantly associated with the occurrence of lactic acidosis (specificity: 92.9%; sensitivity: 67.1%;
186 An infant presented with fatal infantile lactic acidosis and cardiomyopathy, and was found to hav
187 , aminoaciduria, cholestasis, iron overload, lactic acidosis and early death (GRACILE syndrome), and
191 suggestive of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrom
192 ease MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome.
195 e role played by the tumor microenvironment, lactic acidosis in particular, on the uptake by tumor ce
198 fection who all presented with severe type B lactic acidosis shortly after starting treatment with om
199 h a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-o
200 hold causes mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes (MELAS) syndro
201 mino acid supplies, glucose deprivation, and lactic acidosis, all of which pose challenges for protei
203 ssociated with a clinical triad of myopathy, lactic acidosis, and sideroblastic anemia in predominant
206 d multi-organ derangement with leukocytosis, lactic acidosis, haemolytic anaemia and hyperbilirubinem
207 Blood data were consistent with extreme lactic acidosis, reduced glomerular filtration, and stre
216 olic, glutaric, malic, acetic, gluconic, and lactic acids were responsible for the differentiation be
217 increased relative and absolute abundance of lactic and acetic acid bacteria (LAB/AAB) and bacterial
219 cid hydrolysis of oleuropein was faster with lactic and citric acids than acetic acid, running the ex
221 TTB did not exhibit any undesired effect on lactic bacteria which are necessary for development of a
222 in the order of benzoic > acetic > formic > lactic, both in synthetic lipid vesicles and the plasma
225 radable polymeric implant made from poly(D,L-lactic co glycolic acid) (PLGA), and can be used as a gu
226 nthesis, that hydrolytic degradation of poly(lactic- co-glycolic acid)s is dramatically affected by s
227 )(,)(l)(-)lactic acid (PLA)/poly (d)(,)(l)(-)lactic-co-glycolic acid (PLGA) (75:25 w/w) or PHB as enc
228 amide)-carboxymethyl chitosan shell and poly lactic-co-glycolic acid (PLGA) core for enhancing locali
229 Trolox was conjugated on the surface of poly-lactic-co-glycolic acid (PLGA) nanoparticles for the pro
230 ated delivery of FDA-approved pegylated poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with
232 ly, biodegradable poly(ethylene glycol)-poly(lactic-co-glycolic acid) (PEG-PLGA) microparticles were
233 prolactone (PCL) (core layer), a 50:50 poly (lactic-co-glycolic acid) (PLGA) (sheath layer) and a gel
234 e found that use of carboxyl-terminated poly(lactic-co-glycolic acid) (PLGA) allowed encapsulation of
235 rmulated particulate nanocarriers using poly(lactic-co-glycolic acid) (PLGA) and PLGA-polyethylene gl
236 conventional hydrolytically degradable poly(lactic-co-glycolic acid) (PLGA) and reactive oxygen spec
237 r hybrid nanoparticles (CSLPHNPs) with poly (lactic-co-glycolic acid) (PLGA) core and lipid layer con
238 tial electrospinning, consists of a poly(D,L-lactic-co-glycolic acid) (PLGA) fiber layer sandwiched b
240 d within the scaffolds and accommodated poly(lactic-co-glycolic acid) (PLGA) microparticulate systems
242 We developed Sunb-malate loaded poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres (Sunb-malat
243 ve steroid is released for 4 weeks from poly(lactic-co-glycolic acid) (PLGA) microspheres embedded in
244 to prepare injectable and biodegradable poly(lactic-co-glycolic acid) (PLGA) microspheres encapsulati
245 rowth factor were entrapped within the poly (lactic-co-glycolic acid) (PLGA) nanoparticle, which was
246 coustically silent reduced state inside poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PTX-MB@PL
247 E2 and NS3 proteins formulated in poly-(D, L-lactic-co-glycolic acid) (PLGA) nanoparticles adjuvanted
248 e materials, including the widely used poly (lactic-co-glycolic acid) (PLGA) nanoparticles contained
250 - and CMI-inducing adjuvant based on poly(dl-lactic-co-glycolic acid) (PLGA) nanoparticles modified w
251 To improve the activity of the peptide, poly(lactic-co-glycolic acid) (PLGA) nanoparticles were surfa
253 e engineered fluorescent, biodegradable poly(lactic-co-glycolic acid) (PLGA) NPs in a range of sizes
256 examined this hypothesis by assembling poly (lactic-co-glycolic acid) (PLGA) particles loaded with th
257 t to test the hypothesis that inhalable poly(lactic-co-glycolic acid) (PLGA) particles of sildenafil
258 igates the use of nitrofurantoin loaded poly(lactic-co-glycolic acid) (PLGA) particles to improve del
259 r "barcoding" nanoparticles composed of poly(lactic-co-glycolic acid) (PLGA) with bright, spectrally
260 d PNAs targeting miRNA-155 and employed poly(lactic-co-glycolic acid) (PLGA)-based nanoparticle formu
261 f polymers with distinct functions: (i) poly(lactic-co-glycolic acid) (PLGA, P) serving as the main d
262 )-block-poly(ethylene glycol)-block-poly(d,l-lactic-co-glycolic acid) (PLGA-b-PEG-b-PLGA) thermosensi
264 ated that carboxyl functionalization of poly(lactic-co-glycolic acid) can achieve great material homo
265 tic mesoporous silica nanoparticles and poly(lactic-co-glycolic acid) for the delivery and controlled
266 organ toxicity, bevacizumab-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles (PLGA NP) were de
267 Using this method, we found that 80 nm poly(lactic-co-glycolic acid) nanoparticles had maximal K(tra
269 -dimensional (3D)-printed biodegradable poly(lactic-co-glycolic acid) scaffolds (PLGA), and hydroxyap
270 ding ascorbic acid (AA) in the core and poly(lactic-co-glycolic acid) shell incorporating iron oxide
271 composed of 90% hydroxyapatite and 10% poly(lactic-co-glycolic acid) were printed using a microextru
272 t of vaccine cores and shells made from poly(lactic-co-glycolic acid) with varying degradability kine
273 n cancer, fluorescently labeled silica, poly(lactic-co-glycolic acid), and polystyrene nanoparticles
274 rs consist of poly(butylcyanoacrylate), poly(lactic-co-glycolic acid), poly(lactic acid) NPs, liposom
276 he effect of thermosensitive hydrogels (poly(lactic-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(
277 adium(II) dichloride in a biocompatible poly(lactic-co-glycolic acid)-b-polyethyleneglycol platform.
278 ing and solubilization of EpoB in a poly(d,l-lactic-co-glycolic acid)-block-poly(ethylene glycol)-blo
279 lycolic acid)-b-poly(ethylene glycol)-b-poly(lactic-co-glycolic acid); PLGA-PEG-PLGA) for increasing
280 ficacy of a moldable alloplastic graft, Poly Lactic-Co-Glycolic Acid-Coated beta-Tricalcium Phosphate
281 technique with a blend of FDA-approved poly lactic-co-glycolic acid-polyethylene glycol (PLGA_PEG) p
282 s low dose locally-delivered Scl-Ab via poly(lactic-co-glycolic) acid (PLGA) microspheres (MSs) was c
284 tor 4 (TLR4) and TLR7/8 encapsulated in poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles (NPs
285 ilizing a rapid prime-boost protocol of poly(lactic-co-glycolic) acid microparticles and a replicatio
286 SCs incorporated in a uniquely designed poly(lactic-co-glycolic) acid scaffold, a clinically safe pol
287 inistration-approved 500nm carboxylated-poly(lactic-co-glycolic) acid, were infused intravenously int
289 overcome this limitation, electrospun poly (lactic-co-glycolide) (PLGA) mats, which have excellent b
291 omonomers with imbedded monomer sequences of lactic, glycolic, 6-hydroxy hexanoic, and syringic acids
292 review: monocarboxylic acids (like glycolic, lactic, hydroxypropanoic, methyl vinyl glycolic, methyl-
293 Montilla-Moriles Reserva (MRE) had 'buttery-lactic' impact odorants, while 'empyreumatic' and 'sweet
296 r alcohols significantly suppress strawberry/lactic/red fruity, coconut/wood/vanilla and humidity/TCA
297 g to their aromatic character: cheesy-butter-lactic, sweet, flower, empyreumatic, fruity, chemical an
299 also compared the mortality of patients with lactic, unmeasured anions, and hyperchloremic metabolic